[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fvpvcaWOMsWA6ub-GgbuWh5n7suXfqByCj45j5EHwYJA":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"University College Cork",[4],114,false,22,3,21430,0,104,[14,17,20,23,25,27,30,32],{"name":15,"count":16},"Healthy",8,{"name":18,"count":19},"Vitamin D Deficiency",6,{"name":21,"count":22},"Obesity",4,{"name":24,"count":9},"Crohn's Disease",{"name":26,"count":9},"Hypertension",{"name":28,"count":29},"Breast Cancer",2,{"name":31,"count":29},"Pain",{"name":33,"count":29},"Adverse Drug Reactions",[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[43,75,93,123,141,168,186,214,232,257,281,307,333,360,387],{"intervention":44,"totalTrials":45,"cells":46},"continuous infusion of levobupivacaine",1,{"EARLY_PHASE1":47,"PHASE1":49,"PHASE2":51,"PHASE3":53,"PHASE4":55,"NA":73},{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[],{"trials":56,"activeCount":11},[57],{"nctId":58,"briefTitle":59,"status":60,"phases":61,"primaryCompletion":62,"completion":63,"start":64,"enrollment":65,"conditions":66,"interventions":71},"NCT06864312","Rebound Pain Following Regional Anaesthesia for Ankle Fracture Surgery","COMPLETED",[40],"2025-01-28","2025-01-31","2023-10-16",120,[67,68,69,70],"Ankle Fracture (bimalleolar Equivalent, Bimalleolar, or Trimalleolar)","Ankle Fracture - Lateral Malleolus","Ankle Fracture - Medial Malleolus","Rebound Pain",[44,72],"oxycodone",{"trials":74,"activeCount":11},[],{"intervention":72,"totalTrials":45,"cells":76},{"EARLY_PHASE1":77,"PHASE1":79,"PHASE2":81,"PHASE3":83,"PHASE4":85,"NA":91},{"trials":78,"activeCount":11},[],{"trials":80,"activeCount":11},[],{"trials":82,"activeCount":11},[],{"trials":84,"activeCount":11},[],{"trials":86,"activeCount":11},[87],{"nctId":58,"briefTitle":59,"status":60,"phases":88,"primaryCompletion":62,"completion":63,"start":64,"enrollment":65,"conditions":89,"interventions":90},[40],[67,68,69,70],[44,72],{"trials":92,"activeCount":11},[],{"intervention":94,"totalTrials":45,"cells":95},"Dopamine hydrochloride",{"EARLY_PHASE1":96,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":119,"NA":121},{"trials":97,"activeCount":11},[],{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[],{"trials":103,"activeCount":11},[104],{"nctId":105,"briefTitle":106,"status":107,"phases":108,"primaryCompletion":109,"completion":110,"start":111,"enrollment":112,"conditions":113,"interventions":117},"NCT01482559","Management of Hypotension In the Preterm Infant","TERMINATED",[39],"2017-09","2019-10","2015-02",58,[114,115,116],"Hypotension","Low Blood Pressure","Intraventricular Hemorrhage of Prematurity",[94,118],"Dextrose 5%",{"trials":120,"activeCount":11},[],{"trials":122,"activeCount":11},[],{"intervention":118,"totalTrials":45,"cells":124},{"EARLY_PHASE1":125,"PHASE1":127,"PHASE2":129,"PHASE3":131,"PHASE4":137,"NA":139},{"trials":126,"activeCount":11},[],{"trials":128,"activeCount":11},[],{"trials":130,"activeCount":11},[],{"trials":132,"activeCount":11},[133],{"nctId":105,"briefTitle":106,"status":107,"phases":134,"primaryCompletion":109,"completion":110,"start":111,"enrollment":112,"conditions":135,"interventions":136},[39],[114,115,116],[94,118],{"trials":138,"activeCount":11},[],{"trials":140,"activeCount":11},[],{"intervention":142,"totalTrials":45,"cells":143},"Bifidobacterium infantis 35624",{"EARLY_PHASE1":144,"PHASE1":146,"PHASE2":148,"PHASE3":150,"PHASE4":164,"NA":166},{"trials":145,"activeCount":11},[],{"trials":147,"activeCount":11},[],{"trials":149,"activeCount":11},[],{"trials":151,"activeCount":11},[152],{"nctId":153,"briefTitle":154,"status":155,"phases":156,"completion":157,"start":158,"enrollment":159,"conditions":160,"interventions":162},"NCT00510978","Probiotics in GastroIntestinal Disorders","UNKNOWN",[38,39],"2007-11","2002-01",360,[161,24],"Ulcerative Colitis",[142,163],"Lactobacillus salivarius UCC118",{"trials":165,"activeCount":11},[],{"trials":167,"activeCount":11},[],{"intervention":163,"totalTrials":45,"cells":169},{"EARLY_PHASE1":170,"PHASE1":172,"PHASE2":174,"PHASE3":176,"PHASE4":182,"NA":184},{"trials":171,"activeCount":11},[],{"trials":173,"activeCount":11},[],{"trials":175,"activeCount":11},[],{"trials":177,"activeCount":11},[178],{"nctId":153,"briefTitle":154,"status":155,"phases":179,"completion":157,"start":158,"enrollment":159,"conditions":180,"interventions":181},[38,39],[161,24],[142,163],{"trials":183,"activeCount":11},[],{"trials":185,"activeCount":11},[],{"intervention":187,"totalTrials":45,"cells":188},"mecasermin",{"EARLY_PHASE1":189,"PHASE1":191,"PHASE2":193,"PHASE3":208,"PHASE4":210,"NA":212},{"trials":190,"activeCount":11},[],{"trials":192,"activeCount":11},[],{"trials":194,"activeCount":11},[195],{"nctId":196,"briefTitle":197,"status":60,"phases":198,"primaryCompletion":199,"completion":200,"start":201,"enrollment":202,"conditions":203,"interventions":206},"NCT01438086","Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack",[37,38],"2016-02","2016-12","2011-10",47,[204,205],"Heart Failure","Myocardial Infarction",[187,187,207],"0.9% sodium chloride",{"trials":209,"activeCount":11},[],{"trials":211,"activeCount":11},[],{"trials":213,"activeCount":11},[],{"intervention":207,"totalTrials":45,"cells":215},{"EARLY_PHASE1":216,"PHASE1":218,"PHASE2":220,"PHASE3":226,"PHASE4":228,"NA":230},{"trials":217,"activeCount":11},[],{"trials":219,"activeCount":11},[],{"trials":221,"activeCount":11},[222],{"nctId":196,"briefTitle":197,"status":60,"phases":223,"primaryCompletion":199,"completion":200,"start":201,"enrollment":202,"conditions":224,"interventions":225},[37,38],[204,205],[187,187,207],{"trials":227,"activeCount":11},[],{"trials":229,"activeCount":11},[],{"trials":231,"activeCount":11},[],{"intervention":233,"totalTrials":45,"cells":234},"Bupivacaine continuous",{"EARLY_PHASE1":235,"PHASE1":237,"PHASE2":239,"PHASE3":241,"PHASE4":243,"NA":245},{"trials":236,"activeCount":11},[],{"trials":238,"activeCount":11},[],{"trials":240,"activeCount":11},[],{"trials":242,"activeCount":11},[],{"trials":244,"activeCount":11},[],{"trials":246,"activeCount":11},[247],{"nctId":248,"briefTitle":249,"status":60,"phases":250,"primaryCompletion":251,"completion":252,"start":253,"enrollment":254,"conditions":255,"interventions":256},"NCT02897934","CWI and Discharge After Breast Cancer Surgery",[],"2018-01-01","2018-07-31","2016-08",10,[28,31],[233],{"intervention":258,"totalTrials":45,"cells":259},"Probiotic",{"EARLY_PHASE1":260,"PHASE1":262,"PHASE2":264,"PHASE3":266,"PHASE4":268,"NA":270},{"trials":261,"activeCount":11},[],{"trials":263,"activeCount":11},[],{"trials":265,"activeCount":11},[],{"trials":267,"activeCount":11},[],{"trials":269,"activeCount":11},[],{"trials":271,"activeCount":11},[272],{"nctId":273,"briefTitle":274,"status":60,"phases":275,"primaryCompletion":276,"completion":276,"start":277,"enrollment":278,"conditions":279,"interventions":280},"NCT05942586","The Symbiont-Restore Study",[41],"2024-12-04","2023-05-22",137,[21],[258],{"intervention":282,"totalTrials":45,"cells":283},"Continuous Bupivacaine via Adductor Canal Saphenous Catheter",{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":292,"NA":294},{"trials":285,"activeCount":11},[],{"trials":287,"activeCount":11},[],{"trials":289,"activeCount":11},[],{"trials":291,"activeCount":11},[],{"trials":293,"activeCount":11},[],{"trials":295,"activeCount":11},[296],{"nctId":297,"briefTitle":298,"status":60,"phases":299,"primaryCompletion":300,"completion":301,"start":302,"enrollment":303,"conditions":304,"interventions":306},"NCT03145584","Continuous Versus Single-Shot Adductor Canal Block in Total Knee Arthroplasty",[41],"2015-12-20","2015-12-31","2015-07",40,[305],"Pain, Postoperative",[282],{"intervention":308,"totalTrials":45,"cells":309},"Lidocain",{"EARLY_PHASE1":310,"PHASE1":312,"PHASE2":314,"PHASE3":316,"PHASE4":318,"NA":320},{"trials":311,"activeCount":11},[],{"trials":313,"activeCount":11},[],{"trials":315,"activeCount":11},[],{"trials":317,"activeCount":11},[],{"trials":319,"activeCount":11},[],{"trials":321,"activeCount":11},[322],{"nctId":323,"briefTitle":324,"status":155,"phases":325,"primaryCompletion":326,"completion":327,"start":328,"enrollment":329,"conditions":330,"interventions":332},"NCT05002725","PENG Versus Femoral Nerve Block in Neck of Femur Fracture",[41],"2021-09-01","2021-12-01","2021-01-28",64,[331],"Neck of Femur Fracture",[308],{"intervention":334,"totalTrials":45,"cells":335},"Bupivacaine Hydrochloride 20ml injectate",{"EARLY_PHASE1":336,"PHASE1":338,"PHASE2":340,"PHASE3":342,"PHASE4":344,"NA":346},{"trials":337,"activeCount":11},[],{"trials":339,"activeCount":11},[],{"trials":341,"activeCount":11},[],{"trials":343,"activeCount":11},[],{"trials":345,"activeCount":11},[],{"trials":347,"activeCount":11},[348],{"nctId":349,"briefTitle":350,"status":155,"phases":351,"primaryCompletion":352,"completion":353,"start":354,"enrollment":355,"conditions":356,"interventions":359},"NCT05095025","PENG: an Estimation of ED50 in Neck of Femur Fracture",[41],"2022-09-01","2022-10-01","2021-09-14",50,[357,358],"Hip Fractures","Pain, Acute",[334],{"intervention":361,"totalTrials":45,"cells":362},"Ceftazidime",{"EARLY_PHASE1":363,"PHASE1":365,"PHASE2":367,"PHASE3":369,"PHASE4":371,"NA":373},{"trials":364,"activeCount":11},[],{"trials":366,"activeCount":11},[],{"trials":368,"activeCount":11},[],{"trials":370,"activeCount":11},[],{"trials":372,"activeCount":11},[],{"trials":374,"activeCount":11},[375],{"nctId":376,"briefTitle":377,"status":60,"phases":378,"primaryCompletion":379,"completion":380,"start":381,"enrollment":382,"conditions":383,"interventions":385},"NCT02526004","Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified",[41],"2017-06-30","2018-06-30","2013-10-01",223,[384],"Cystic Fibrosis",[361,386],"Tobramycin",{"intervention":386,"totalTrials":45,"cells":388},{"EARLY_PHASE1":389,"PHASE1":391,"PHASE2":393,"PHASE3":395,"PHASE4":397,"NA":399},{"trials":390,"activeCount":11},[],{"trials":392,"activeCount":11},[],{"trials":394,"activeCount":11},[],{"trials":396,"activeCount":11},[],{"trials":398,"activeCount":11},[],{"trials":400,"activeCount":11},[401],{"nctId":376,"briefTitle":377,"status":60,"phases":402,"primaryCompletion":379,"completion":380,"start":381,"enrollment":382,"conditions":403,"interventions":404},[41],[384],[361,386]]